Skip to content
Back to Guavy Wire
Stocks

P&G Scoops Up Thorne for $3.8B Wellness Boost

Instruments
PG
Share

Procter & Gamble has agreed to acquire Thorne, a supplements company, for $3.8 billion in cash. This deal aims to strengthen P&G's wellness offering by expanding its personal health care portfolio.

The transaction is expected to close later this year, subject to regulatory approvals. P&G will acquire Thorne from L Catterton's Flagship Fund.

P&G CEO Shailesh Jejurikar said that the company is 'happy' with the asset and described it as a well-run operation. The acquisition of Thorne will complement P&G's existing portfolio in premium wellness.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc